Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 03, 2022 08:36 ET | Source: Staffing 360 Solutions, Inc.

Multiple Brands in the Staffing 360 Solutions Organization Receive Exceptional Client Service Awards

NEW YORK, Feb. 03, 2022 (GLOBE NEWSWIRE) -- Staffing 360 Solutions, Inc. (NASDAQ: STAF), a company executing an international buy-integrate-build strategy through the acquisition of staffing...
February 03, 2022 08:00 ET | Source: Pasithea

Pasithea Therapeutics Initiates New Chemical Entity Drug Development Program in Multiple Sclerosis

MIAMI BEACH, Fla., Feb. 03, 2022 (GLOBE NEWSWIRE) -- Pasithea Therapeutics Corp. (Nasdaq: KTTA) (“Pasithea” or the “Company”), a biotechnology company focused on the research and discovery of new...
February 03, 2022 06:00 ET | Source: Zoho Corporation

Zoho Workplace Touts Consecutive Years of Exceptional Growth and Record Migrations from Competitor Suites

Austin, Texas, Feb. 03, 2022 (GLOBE NEWSWIRE) -- Zoho Corporation, a global technology company offering the most comprehensive suite of business software applications in the industry, today...
February 02, 2022 16:30 ET | Source: ORIC Pharmaceuticals

ORIC Pharmaceuticals to Participate in the Guggenheim 2022 Oncology Conference

SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, Feb. 02, 2022 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage oncology company focused on developing treatments that...
February 01, 2022 07:01 ET | Source: CWD GLOBAL DAO

CWD GLOBAL Expands DAO Capabilities

DUBAI, United Arab Emirates, Feb. 01, 2022 (GLOBE NEWSWIRE) -- CWD GLOBAL is a decentralized platform with a strong team of industry leaders and professionals behind it, who work hard on a daily...
February 01, 2022 07:00 ET | Source: Anavex Life Sciences Corp.

ANAVEX®2-73 (Blarcamesine) AVATAR Phase 3 Trial met Primary and Secondary Efficacy Endpoints for the Treatment of Adult Patients with Rett Syndrome

Primary and all secondary efficacy and safety endpoints met, with consistent improvements in RSBQ AUC (p = 0.037), ADAMS (p = 0.010) and CGI-I (p = 0.037) response Efficacy endpoints demonstrated...
January 26, 2022 17:20 ET | Source: NOVAGOLD RESOURCES INC.

NOVAGOLD Reports Fiscal Year 2021 Financial Results

Multiple High-Grade Intercepts Recorded at Donlin Gold’s Successful 2021 Drilling Program Additional State Permits Received Strong Cash Position Maintained The Donlin Gold project (“Donlin Gold”...
January 25, 2022 11:30 ET | Source: Lava for Good

Lava For Good Podcasts Honored with Anthem Award Nomination

NEW YORK, Jan. 25, 2022 (GLOBE NEWSWIRE) -- Lava For Good Podcasts is proud to be recognized by The Anthem Awards with a nomination in the Human & Civil Rights - Best Strategy category. The news...
January 25, 2022 09:54 ET | Source: Berkeley College

U.S. News & World Report Ranks Berkeley College among Best Online Bachelor's Degree Programs for 9th Consecutive Year

WOODLAND PARK, NJ, Jan. 25, 2022 (GLOBE NEWSWIRE) -- For the ninth consecutive year, U.S. News & World Report has ranked Berkeley College among the Best Colleges in the nation for Online...
January 25, 2022 08:30 ET | Source: ORIC Pharmaceuticals

ORIC Pharmaceuticals Announces Regulatory Clearance of Clinical Trial Application for ORIC-114 in Advanced Solid Tumors with EGFR or HER2 Exon 20 Alterations or HER2 Amplifications

SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, Jan. 25, 2022 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage oncology company focused on developing treatments that...